South African study of blast phase chronic myeloid leukaemia: A poor prognostic outlook
Background: Chronic myeloid leukaemia (CML) is a haematological malignancy characterised by the translocation t(9;22)(q34;q11.2), resulting in a constitutively active tyrosine kinase. Globally, overall survival of blast crisis phase (BC) CML is one year. Newer tyrosine kinase inhibitors and allogene...
Saved in:
Main Authors: | Katherine E. Hodkinson (Author), Nikki Bouwer (Author), Jenifer Vaughan (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases
by: Ruixin Gu, et al.
Published: (2022) -
Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023) -
Two Cases of Chronic Myeloid Leukemia in Lymphoid Blast Phase Presented as Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Tae Hoon Lee, et al.
Published: (2023) -
The Biology and Treatment of Myeloid Leukaemias
by: Ewa Marcinkowska (Ed.)
Published: (2018) -
Exploring the acute myeloid leukaemias
by: TB Thapa
Published: (2013)